Evaluation of Effectiveness and Safety of BIOMATRIX in Routine Clinical Practice; A Multicenter, Prospective Observational Study.
Phase of Trial: Phase IV
Latest Information Update: 15 Dec 2016
At a glance
- Drugs Umirolimus (Primary) ; Paclitaxel; Sirolimus
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms IRIS-BIOMATRIX
- 10 Jun 2017 Biomarkers information updated
- 11 Dec 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Jul 2018.
- 29 Jun 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2020.